Skin Cancer Drugs Market by Type (Chemotherapy, Immunotherapy), Disease Indication (Melanoma, Basal and Squamous), Distribution Channel – Global Forecast to 2027
The global skin cancer drugs market is projected to reach USD ~6 billion by 2027 from USD 4 billion in 2022, at a CAGR of 9 % during the forecast period
To know about the assumptions considered for the study, Request for Free Sample Report
Skin cancer is an uncontrolled proliferation of aberrant skin cells that results in the formation of malignant tumours. Skin cancer can be of various types including basal cell carcinoma, squamous cell carcinoma or melanoma, etc. Some of the examples of skin cancer drugs include Aldara (Imiquimod), 5-FU (Fluorouracil--Topical) , Etude etc.
The global skin cancer drugs market has witnessed promising growth in recent years. This progress can be attributed to the growing patient population for skin cancer. According to the American Cancer Society (ACS), skin cancer is the most diagnosed cancer in the US, with more than 5 million new cases diagnosed each year. This has led to an increased demand for new and innovative skin cancer drugs which is likely to drive the growth of the market in the coming years.
To know about the assumptions considered for the study, download the pdf brochure
The global skin cancer drugs market is segmented on the basis of type, disease indication, distribution channel, and region. On the basis of type, the market is divided into chemotherapy, immunotherapy, targeted therapy, and others. Based on the disease indication, the market is segmented into melanoma, basal and squamous cell skin cancer, and others. Based on distribution channel, the market is classified into hospital pharmacies, specialty and retail pharmacies, and others.
On the basis of region, the market is segmented into the North America, Europe, Asia Pacific, and the Rest of the World (RoW) which includes the Latin America and Middle East & Africa.
The major players in the skin cancer drugs market are Novartis AG, Bristol Myers Squibb, Eli Lilly, Meda, Sun Pharmaceutical Industries Ltd, Roche, Aqua Pharmaceuticals, Bausch Health, GlaxoSmithKline PLC, and Pfizer Inc.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKET COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.1.2.1 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET GROWTH RATE PROJECTIONS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.4 PRICING ANALYSIS
5.5 VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
5.7 PATENT ANALYSIS
5.8 KEY CONFERENCES AND EVENTS IN 2022-2023
5.9 REGULATORY ANALYSIS
5.10 PORTER’S FIVE FORCES ANALYSIS
5.11 KEY STAKEHOLDER AND BUYING CRITERIA
6 SKIN CANCER DRUGS MARKET, BY TYPE, 2020-2027 (USD MILLION)
6.1 INTRODUCTION
6.2 CHEMOTHERAPY
6.3 IMMUNOTHERAPY
6.4 TARGETED THERAPY
6.5 OTHERS
7 SKIN CANCER DRUGS MARKET, BY DISEASE INDICATION, 2020-2027 (USD MILLION)
7.1 MELANOMA
7.2 BASAL AND SQUAMOUS CELL SKIN CANCER
7.3 OTHERS
8 SKIN CANCER DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
8.1 INTRODUCTION
8.2 HOSPITAL PHARMACIES
8.3 SPECIALTY & RETAIL PHARMACIES
8.4 OTHERS
9 SKIN CANCER DRUGS MARKET, BY REGION, 2020-2027 (USD MILLION)
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 UK
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 ROE
9.4 ASIA PACIFIC
9.4.1 JAPAN
9.4.2 CHINA
9.4.3 INDIA
9.4.4 REST OF APAC
9.5 REST OF THE WORLD (ROW)
9.5.1 LATIN AMERICA
9.5.2 MIDDLE EAST & AFRICA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
10.4 MARKET SHARE ANALYSIS, 2021
10.5 COMPANY EVALUATION QUADRANT
10.6 COMPANY EVALUATION QUADRANT – SME/START-UPS
10.7 COMPANY GEOGRAPHIC FOOTPRINT
10.8 COMPETITIVE SCENARIO
11 COMPANY PROFILES
(The details on business overview, financial information, products/services portfolio, recent developments, MarketsandMarkets view will be provided)*
11.1 FIREFLY
11.2 SKINIO
11.3 CANFIELD SCIENTIFIC, INC.
11.4 FOTOFINDER SYSTEMS, INC.
11.5 3GEN
11.6 METAOPTIMA
11.7 AGILENT TECHNOLOGIES
11.8 SKINVISION
11.9 SPECLIPSE, INC.
11.10 SKIN ANALYTICS
* Details on business overview, financial information, products/services portfolio, recent developments, MarketsandMarkets view might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
12.7 AUTHOR DETAILS
Growth opportunities and latent adjacency in Skin Cancer Drugs Market